Pancreatic Acinar Cell Carcinoma Active Not Recruiting Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0040329 (Pancreatic Acinar Cell Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00878163GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryTreatment